CABOZANTINIB HAS ACTIVITY IN CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2013年 / 3卷 / 01期
关键词：
D O I：
10.1158/2159-8290.CD-RW2012-216
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [21] Denosumab in castration-resistant prostate cancer
    Kyrgidis, Athanassios
    Tzellos, Thrasivoulos-George
    LANCET, 2012, 379 (9828): : E50 - E50
  • [22] Corticotherapy in castration-resistant prostate cancer
    Lebdai, S.
    Branchereau, J.
    Robert, G.
    De La Tallie, A.
    Bouchaert, P.
    PROGRES EN UROLOGIE, 2013, 23 : S23 - S33
  • [23] Enzalutamide in Castration-Resistant Prostate Cancer
    Anker, Markus S.
    Lehmann, Lorenz H.
    Anker, Stefan D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1380 - 1380
  • [24] Nonmetastatic Castration-Resistant Prostate Cancer
    Hong, Jun Hyuk
    Kim, Isaac Y.
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (03) : 153 - 160
  • [25] Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer
    Di Nunno, Vincenzo
    Cimadamore, Alessia
    Santoni, Matteo
    Scarpelli, Marina
    Fiorentino, Michelangelo
    Ciccarese, Chiara
    Iacovelli, Roberto
    Cheng, Liang
    Lopez-Beltran, Antonio
    Massari, Francesco
    Montironi, Rodolfo
    FUTURE ONCOLOGY, 2018, 14 (25) : 2559 - 2564
  • [26] Evaluation of cabozantinib in combination with abiraterone, enzalutamide or docetaxel in a castration-resistant prostate cancer xenograft in vivo
    Nguyen, Holly M.
    Brown, Lisha G.
    Olson, Jessica L.
    Aftab, Dana T.
    Vessella, Robert L.
    Corey, Eva
    CANCER RESEARCH, 2014, 74 (19)
  • [27] Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer
    Smith, David C.
    Daignault-Newton, Stephanie
    Grivas, Petros
    Reichert, Zachery R.
    Hussain, Maha
    Cooney, Kathleen A.
    Caram, Megan
    Alva, Ajjai
    Jacobson, Jon
    Yablon, Corrie
    Mehra, Rohit
    Escara-Wilke, June
    Shelley, Greg
    Keller, Evan T.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (04) : 332 - +
  • [28] A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases
    Lee, Richard J.
    Saylor, Philip J.
    Michaelson, M. Dror
    Rothenberg, S. Michael
    Smas, Malgorzata E.
    Miyamoto, David T.
    Gurski, Carol A.
    Xie, Wanling
    Maheswaran, Shyamala
    Haber, Daniel A.
    Goldin, Jonathan G.
    Smith, Matthew R.
    CLINICAL CANCER RESEARCH, 2013, 19 (11) : 3088 - 3094
  • [29] Cabozantinib: a novel agent with a dual mechanism of action for castration-resistant prostate carcinoma
    Álvaro Pinto
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 219 - 222
  • [30] Cabozantinib: a novel agent with a dual mechanism of action for castration-resistant prostate carcinoma
    Pinto, Alvaro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (02) : 219 - 222
12345